A detailed history of Consolidated Planning Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Consolidated Planning Corp holds 55,134 shares of NVO stock, worth $4.82 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
55,134
Previous 54,096 1.92%
Holding current value
$4.82 Million
Previous $7.72 Million 14.99%
% of portfolio
1.08%
Previous 1.41%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$119.07 - $145.42 $123,594 - $150,945
1,038 Added 1.92%
55,134 $6.56 Million
Q2 2024

Aug 02, 2024

BUY
$122.71 - $146.91 $207,625 - $248,571
1,692 Added 3.23%
54,096 $7.72 Million
Q1 2024

May 02, 2024

SELL
$102.11 - $135.92 $383,831 - $510,923
-3,759 Reduced 6.69%
52,404 $6.73 Million
Q4 2023

Feb 02, 2024

BUY
$87.78 - $105.45 $37,833 - $45,448
431 Added 0.77%
56,163 $5.81 Million
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $2.59 Million - $5.69 Million
28,521 Added 104.81%
55,732 $5.07 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $43,986 - $48,687
282 Added 1.05%
27,211 $4.4 Million
Q1 2023

May 04, 2023

SELL
$132.34 - $159.14 $1.86 Million - $2.23 Million
-14,038 Reduced 34.27%
26,929 $4.29 Million
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $130,956 - $172,816
1,277 Added 3.22%
40,967 $5.54 Million
Q3 2022

Nov 04, 2022

SELL
$95.28 - $116.93 $110,143 - $135,171
-1,156 Reduced 2.83%
39,690 $3.95 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $4.22 Million - $4.98 Million
40,846 New
40,846 $4.55 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Consolidated Planning Corp Portfolio

Follow Consolidated Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Planning Corp with notifications on news.